Search Results - "Sekar, Kris C"

Protective strategies to prevent patent ductus arteriosus by Sekar, Kris C

“…Ductus arteriosus is the communication between the proximal aorta and the pulmonary artery which diverts well oxygenated blood from the placenta to the…”
Get full text

Trends in conventional mechanical ventilation and pulmonary graphics in the newborn by Sekar, Kris C

“…The optimal treatment for respiratory distress syndrome （RDS） in extremely low birth weight newbom infants now consists of surfactant therapy, ventilator…”
Get full text

Effect of decreasing target oxygen saturation on retinopathy of prematurity by Tlucek, Paul S., MD, Corff, Karen E., MS, ARNP, Bright, Brianna C., MA, Bedwell, Susan M., MS, APRN, Sekar, Kris C., MD, Siatkowski, R. Michael, MD

“…Introduction The authors of previous studies suggest that the oxygenation status of premature infants contributes to the development of retinopathy of…”
Get full text

Early Inhaled Nitric Oxide Therapy in Premature Newborns with Respiratory Failure by Kinsella, John P, Cutter, Gary R, Walsh, William F, Gerstmann, Dale R, Bose, Carl L, Hart, Claudia, Sekar, Kris C, Auten, Richard L, Bhutani, Vinod K, Gerdes, Jeffrey S, George, Thomas N, Southgate, W. Michael, Carriedo, Heather, Couser, Robert J, Mammel, Mark C, Hall, David C, Pappagallo, Mariann, Sardesai, Smeeta, Strain, John D, Baier, Monika, Abman, Steven H

“…In this multicenter, randomized trial of preterm newborns with a birth weight from 500 to 1250 g and with respiratory failure, low-dose inhaled nitric oxide…”
Get full text

Comparison of Amikacin Pharmacokinetics in Neonates With and Without Congenital Heart Disease by Nguyen, Amy L., Johnson, Peter N., Neely, Stephen B., Hughes, Kaitlin M., Sekar, Kris C., Welliver, Robert C., Miller, Jamie L.

“…OBJECTIVESThe primary objective was to compare the volume of distribution (Vd), clearance (CL), elimination rate (Ke), and half-life (t½) of amikacin in…”
Get full text

Comparison of Amikacin Pharmacokinetics in Neonates Following Implementation of a New Dosage Protocol by Hughes, Kaitlin M, Johnson, Peter N, Anderson, Michael P, Sekar, Kris C, Welliver, Robert C, Miller, Jamie L

“…The primary aim was to compare attainment of goal serum amikacin concentrations using two dosage regimens in patients admitted to a neonatal intensive care…”
Get full text

Effect of decreasing target oxygen saturation on ROP by Tlucek, Paul S, Corff, Karen E, Bright, Brianna C, Sekar, Kris C, Siatkowski, R.MIchael

Get full text

Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants by Corff, Karen E, Sekar, Kris C

“…When medical management is warranted for closure of a persistent patent ductus arteriosus (PDA) in premature infants, treatment with a cyclooxygenase (COX)…”
Get full text